Is APLF p.Asn169Asp (c.505A>G) pathogenic?

APLF p.Asn169Asp (c.505A>G) is classified Uncertain significance in APLF (ClinVar, Single submitter, 1 submitter; last evaluated 2021-09-01). AlphaMissense: likely benign (0.0707); Rare (popmax 0.663%, mid).

How common is APLF p.Asn169Asp (c.505A>G) in the general population?

APLF p.Asn169Asp (c.505A>G) is rare (popmax 0.663%, mid) (gnomAD).

What do computational predictors say about APLF p.Asn169Asp (c.505A>G)?

AlphaMissense predicts likely benign (score 0.0707) — an in-silico prediction, not a clinical call.

APLF p.Asn169Asp

c.505A>G · rs145654399 · VCV3127834

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0707 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.663%, mid)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0707	likely benign
REVEL	0.008	strongly benign-leaning
SaProt	LLR -6.79	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -0.68	GERP -5.2
Regional constraint	o/e 1.01	unconstrained · MANE · 110 kb · p 0.73 · regional, not allelic
Overall
CADD	1.611	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.663% Middle Eastern · 40/6,034 alleles

Filtering AF 0.5% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.444%

Overall 0.0567% 913/1,611,128 alleles · rare

Ancestry group	Frequency	1 in
Middle Easterngrpmax	0.663%	151
Ashkenazi Jewishnot grpmax-eligible	0.367%	273
Admixed American	0.101%	995
Remaining individualsnot grpmax-eligible	0.0931%	1,075
South Asian	0.0858%	1,166
European (non-Finnish)	0.0478%	2,093
African / African-American	0.00534%	18,718
Finnishnot grpmax-eligible	0.00312%	32,006

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: APLF
Protein: p.Asn169Asp
Coding: c.505A>G
MANE Select: NM_173545
dbSNP: rs145654399
Type: single nucleotide variant
Location: chr2:68513563 (GRCh38)
Gene constraint: LOEUF 1.451 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 62.42 · 14 PDB

Full APLF gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

APLF p.Ala17Pro Uncertain significance ★ ⚠ same type
APLF p.Ala19Thr Uncertain significance ★ ⚠ same type
APLF p.Arg10Leu Uncertain significance ★ ⚠ same type
APLF p.Arg182Lys Uncertain significance ★ ⚠ same type
APLF p.Arg293Lys Uncertain significance ★ ⚠ same type
APLF p.Arg418Trp Uncertain significance ★ ⚠ same type
APLF p.Arg99His Uncertain significance ★ ⚠ same type
APLF p.Arg99Leu Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/aplf-p-asn169asp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown